STAT3 and pulmonary arterial hypertension: PLIER identified significant enrichment (FDR < 0.05; AUC > 0.6) in pathways such as STAT3 and JNK signaling, both implicated in pulmonary arterial hypertension (PAH) pathogenesis [18,19].